Guangzhou Doublle Bioproduct provides clinical and commercial update on its adenolysine gene therapy asset for head and neck cancer as it seeks global partners Early results from our phase III.
cancer treatment drugs market Latest Research on Global Cancer Treatment Drug Market: report includes forecasts and analyzes at global, regional and country level. The study provides historical information from 2016-2021.
SAN DIEGO, June 09, 2021 (GLOBE NEWSLETTER) -- eFFECTOR Therapeutics, Inc. , a leader in the development of selective translational regulation inhibitors (STRIs) for the treatment of cancer, today announced.
Severance Hospital researchers have identified key factors that can predict patients' responses to anticancer treatments by analyzing bile duct cancer genes from patients with a poor prognosis. Bile duct cancer,.
Each year, an estimated 1.8 million people in the United States are affected by cancer - most common cancers of breast, lung, prostate and blood cancers such as leukemia. Although.
RICHMOND, Va., June 08, 2021 (GLOBE NEWSWIRE) -- The Center for Innovative Technology ( CIT ) announced today that CIT GAP Funds, the direct investment program of the Virginia Innovation.